Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Kuznetsov

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Terapevticheskii Arkhiv|September 11, 1999
[Interferon alfa-2b treatment of adult patients during early chronic phase of Ph1-positive chronic myeloid leukemia (initial report on a cooperative study, protocol CML-MIG-97)]N D Khoroshko, A G Turkina, A V Zakharova, et al.
Physical Chemistry Chemical Physics : PCCP|November 2, 2019
Thermodynamic properties and lattice dynamics investigation of LuB<sub>2</sub>C: experiment and ab initio calculationsI R Shein, V V Novikov, S V Kuznetsov, et al.
Dalton Transactions (Cambridge, England : 2003)|August 29, 2024
Structure and luminescence properties of EuF<sub>3</sub> and SrF<sub>2</sub>:Eu nanoparticles after microwave plasma annealing in "methane-hydrogen"I A Tiazhelov, V S Sedov, A K Martyanov, et al.
Vestnik Oftalmologii|March 18, 2026
[Next-generation pharmaceutically acceptable vehicles for eye drops (preliminary report)]M V Kravchik, I A Novikov, S V Kuznetsov, et al.
Terapevticheskii Arkhiv|August 28, 2009
[Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase]O Iu Vinogradova, A G Turkina, A V Vorontsova, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|November 1, 1996
[Expression of Fas/APO-1/CD95 antigen mediating the apoptosis in human leukemic cells]Iu V Shishkin, N P Sediakhina, T N Zabotina, et al.
Terapevticheskii Arkhiv|September 24, 2004
[Prediction of interferon therapy efficacy in chronic myeloid leukemia according to data of histomorphological study]N D Khoroshko, A G Turkina, S M Kumas, et al.
Terapevticheskii Arkhiv|September 22, 1998
[An evaluation of the prognostic significance of antigen CD95(Fas/APO-1) expression on the cells of patients with a myelodysplastic syndrome, acute myeloid leukemia and chronic myeloleukemia]E R Polosukhina, S V Kuznetsov, N P Logcheva, et al.
Acta Naturae|June 1, 2012
Cell Regulation of Proliferation and Differentiation ex vivo for Cells Containing Ph Chromosome in Chronic Myeloid LeukemiaN I Grineva, T V Akhlynina, L P Gerasimova, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|February 18, 2006
Inverse free electron lasers and laser wakefield acceleration driven by CO2 lasersW D Kimura, N E Andreev, M Babzien, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Terapevticheskii Arkhiv|September 11, 1999
[Interferon alfa-2b treatment of adult patients during early chronic phase of Ph1-positive chronic myeloid leukemia (initial report on a cooperative study, protocol CML-MIG-97)]N D Khoroshko, A G Turkina, A V Zakharova, et al.
Physical Chemistry Chemical Physics : PCCP|November 2, 2019
Thermodynamic properties and lattice dynamics investigation of LuB<sub>2</sub>C: experiment and ab initio calculationsI R Shein, V V Novikov, S V Kuznetsov, et al.
Dalton Transactions (Cambridge, England : 2003)|August 29, 2024
Structure and luminescence properties of EuF<sub>3</sub> and SrF<sub>2</sub>:Eu nanoparticles after microwave plasma annealing in "methane-hydrogen"I A Tiazhelov, V S Sedov, A K Martyanov, et al.
Vestnik Oftalmologii|March 18, 2026
[Next-generation pharmaceutically acceptable vehicles for eye drops (preliminary report)]M V Kravchik, I A Novikov, S V Kuznetsov, et al.
Terapevticheskii Arkhiv|August 28, 2009
[Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase]O Iu Vinogradova, A G Turkina, A V Vorontsova, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|November 1, 1996
[Expression of Fas/APO-1/CD95 antigen mediating the apoptosis in human leukemic cells]Iu V Shishkin, N P Sediakhina, T N Zabotina, et al.
Terapevticheskii Arkhiv|September 24, 2004
[Prediction of interferon therapy efficacy in chronic myeloid leukemia according to data of histomorphological study]N D Khoroshko, A G Turkina, S M Kumas, et al.
Terapevticheskii Arkhiv|September 22, 1998
[An evaluation of the prognostic significance of antigen CD95(Fas/APO-1) expression on the cells of patients with a myelodysplastic syndrome, acute myeloid leukemia and chronic myeloleukemia]E R Polosukhina, S V Kuznetsov, N P Logcheva, et al.
Acta Naturae|June 1, 2012
Cell Regulation of Proliferation and Differentiation ex vivo for Cells Containing Ph Chromosome in Chronic Myeloid LeukemiaN I Grineva, T V Akhlynina, L P Gerasimova, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|February 18, 2006
Inverse free electron lasers and laser wakefield acceleration driven by CO2 lasersW D Kimura, N E Andreev, M Babzien, et al.
Pageof 14